ARTICLE | Finance
Ebb & Flow
April 7, 2008 7:00 AM UTC
For small companies with constrained options in the current financing environment, alternative approaches tied to royalty or revenue interests continue to be the order of the day. Last week, a trio of alternative vehicles went through, two revenue interest financings, one by Paul Capitaland another by Deerfield Capital, and a royalty financing by Deerfield.
Genitourinary company Plethora (LSE:PLE) signed a $25 million revenue interest financing with Paul Capital, with an option for an additional $3 million equity investment...